Assignee
AURANSA INC
US·7 granted patents·4 pending applications·5 citations·filing 2017–2025
Top patents by PatentIndex Score
11 records- 0186US10874633B2Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicityAURANSA INC·Filed 2020·Granted Dec 29, 2020·2 cites·22 claims
- 0284US10806716B2Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicityAURANSA INC·Filed 2017·Granted Oct 20, 2020·2 cites·12 claims
- 0383US11166936B2Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicityAURANSA INC·Filed 2020·Granted Nov 9, 2021·1 cites·19 claims
- 0473US11786503B2Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicityAURANSA INC·Filed 2021·Granted Oct 17, 2023·0 cites·12 claims
- 0556US12286622B2Genomics-based identification and characterization of rare cell typesAURANSA INC·Filed 2019·Granted Apr 29, 2025·0 cites·17 claims
- 0656US2025388542A1Analogues of pentamidine and uses thereforAURANSA INC·Filed 2025·Application pending·0 cites
- 0751US2023391727A1Analogues of pentamidine and methods for treating infectionsAURANSA INC·Filed 2021·Application pending·0 cites
- 0850US2020377510A1Derivatives of piperlongumine and uses thereofAURANSA INC·Filed 2020·Application pending·0 cites
- 0945US12398105B2Analogues of pentamidine and uses thereforAURANSA INC·Filed 2019·Granted Aug 26, 2025·0 cites·25 claims
- 1044US11485725B2Derivatives of piperlongumine and uses thereofAURANSA INC·Filed 2018·Granted Nov 1, 2022·0 cites·23 claims
- 1137US2021378992A1Methods for treating a subtype of small cell lung cancerAURANSA INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AURANSA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →